Effect of Orexin-A on Cortisol Secretion in H295R Cells Via P70S6K/4EBP1 Signaling Pathway

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2015 Jun 12

PMID 26064108

Citations 4

Authors

Xiaocen Chang

Yuyan Zhao

Lei Guo

Affiliations

Soon will be listed here.

Abstract

Orexin-A is a neuropeptide that orchestrates diverse central and peripheral processes. It is now clear that orexin system plays a central role in the regulation of endocrine, paracrine, and neurocrine. It is involved in the regulation of growth hormone, adrenocorticotropic hormone, thyroid, mineralocorticoid, and cortisol secretion. These hormones may also serve as a kind of signal linking energy balance regulation, reproduction, stress response, and cardiovascular regulation. Many studies have demonstrated the ability of orexin-A to regulate adrenocortical cells through the MAPK (mitogen-activated protein kinases) pathway. The aim of our study is to investigate the effect of orexin-A on cortisol secretion via the protein 70 ribosomal protein S6 kinase-1 (p70S6K) and eukaryotic translation initiation factor 4E binding proteins (4EBP1) signaling pathway in adrenocortical cells. We reported the first evidence that orexin-A stimulated p70S6K and 4EBP1 in human H295R adrenocortical cells in a concentration and time-dependent manner. 10(-6) M orexin-A treatment for 1 hour was the most potent. Our results also indicated that p70S6K and 4EBP1 kinases participated in controlling cortisol secretion via OX1 receptor in H295R cells, which implied important role of p70S6K and 4EBP1 kinases in regulating adrenal function induced by orexin-A.

Citing Articles

Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice.

Xue F, Cheng J, Liu Y, Cheng C, Zhang M, Sui W Signal Transduct Target Ther. 2022; 7(1):259.

PMID: 35909160 PMC: 9339545. DOI: 10.1038/s41392-022-01054-3.

RNA-seq expression profiling of rat MCAO model following reperfusion Orexin-A.

Wang C, Pan Y, Liu M, Cheng B, Bai B, Chen J Oncotarget. 2018; 8(68):113066-113081.

PMID: 29348887 PMC: 5762572. DOI: 10.18632/oncotarget.22995.

The wake-promoting drug modafinil stimulates specific hypothalamic circuits to promote adaptive stress responses in an animal model of PTSD.

Cohen S, Ifergane G, Vainer E, Matar M, Kaplan Z, Zohar J Transl Psychiatry. 2016; 6(10):e917.

PMID: 27727245 PMC: 5315545. DOI: 10.1038/tp.2016.172.

Interaction between Angiotensin II and Insulin/IGF-1 Exerted a Synergistic Stimulatory Effect on ERK1/2 Activation in Adrenocortical Carcinoma H295R Cells.

Tong A, Wang F, Cui Y, Li C, Li Y Int J Endocrinol. 2016; 2016:3403292.

PMID: 27293433 PMC: 4880714. DOI: 10.1155/2016/3403292.

References

Magga J, Bart G, Oker-Blom C, Kukkonen J, Akerman K, Nasman J . Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1. Biochem Pharmacol. 2006; 71(6):827-36. DOI: 10.1016/j.bcp.2005.12.021. View

Voisin T, Rouet-benzineb P, Reuter N, Laburthe M . Orexins and their receptors: structural aspects and role in peripheral tissues. Cell Mol Life Sci. 2003; 60(1):72-87. PMC: 11138506. DOI: 10.1007/s000180300005. View

Spinazzi R, Rucinski M, Neri G, Malendowicz L, Nussdorfer G . Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells. J Clin Endocrinol Metab. 2005; 90(6):3544-9. DOI: 10.1210/jc.2004-2385. View

Urbanska A, Sokolowska P, Woldan-Tambor A, Bieganska K, Brix B, Johren O . Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J Mol Neurosci. 2011; 46(1):10-7. PMC: 3260434. DOI: 10.1007/s12031-011-9526-2. View

Xu T, Yang Y, Ward R, Gao L, Liu Y . Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cell Signal. 2013; 25(12):2413-23. DOI: 10.1016/j.cellsig.2013.07.025. View

Grozinsky-Glasberg S, Franchi G, Teng M, Leontiou C, de Oliveira Jr A, Dalino P . Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line. Neuroendocrinology. 2007; 87(3):168-81. DOI: 10.1159/000111501. View

Mazzocchi G, Malendowicz L, Gottardo L, Aragona F, Nussdorfer G . Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade. J Clin Endocrinol Metab. 2001; 86(2):778-82. DOI: 10.1210/jcem.86.2.7233. View

De Martino M, Feelders R, de Herder W, Van Koetsveld P, Dogan F, Janssen J . Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors. Endocr Relat Cancer. 2014; 21(4):601-13. DOI: 10.1530/ERC-13-0112. View

Samuels Y, Velculescu V . Oncogenic mutations of PIK3CA in human cancers. Cell Cycle. 2004; 3(10):1221-4. DOI: 10.4161/cc.3.10.1164. View

10.

Zhu Y, Miwa Y, Yamanaka A, Yada T, Shibahara M, Abe Y . Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins. J Pharmacol Sci. 2003; 92(3):259-66. DOI: 10.1254/jphs.92.259. View

11.

Harthill J, Pozuelo Rubio M, Milne F, Mackintosh C . Regulation of the 14-3-3-binding protein p39 by growth factors and nutrients in rat PC12 pheochromocytoma cells. Biochem J. 2002; 368(Pt 2):565-72. PMC: 1223016. DOI: 10.1042/BJ20020838. View

12.

Chen L, Zhao Y, Zheng D, Ju S, Shen Y, Guo L . Orexin A Affects INS-1 Rat Insulinoma Cell Proliferation via Orexin Receptor 1 and the AKT Signaling Pathway. Int J Endocrinol. 2014; 2013:854623. PMC: 3871501. DOI: 10.1155/2013/854623. View

13.

Heinonen M, Purhonen A, Makela K, Herzig K . Functions of orexins in peripheral tissues. Acta Physiol (Oxf). 2008; 192(4):471-85. DOI: 10.1111/j.1748-1716.2008.01836.x. View

14.

Ramanjaneya M, Conner A, Chen J, Kumar P, Brown J, Johren O . Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B. J Endocrinol. 2009; 202(2):249-61. DOI: 10.1677/JOE-08-0536. View

15.

Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C . The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004; 10(5):484-6. DOI: 10.1038/nm1042. View

16.

Furic L, Rong L, Larsson O, Koumakpayi I, Yoshida K, Brueschke A . eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci U S A. 2010; 107(32):14134-9. PMC: 2922605. DOI: 10.1073/pnas.1005320107. View

17.

Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli R, Tanaka H . Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998; 92(4):573-85. DOI: 10.1016/s0092-8674(00)80949-6. View

18.

Doghman M, Lalli E . Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma. Mol Cell Endocrinol. 2012; 364(1-2):101-4. DOI: 10.1016/j.mce.2012.08.014. View

19.

Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F . Immunoreactive orexin-A in human plasma. Peptides. 2001; 22(1):139-42. DOI: 10.1016/s0196-9781(00)00369-7. View

20.

Malendowicz L, Jedrzejczak N, Belloni A, Trejter M, Hochol A, Nussdorfer G . Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands. Histol Histopathol. 2001; 16(3):713-7. DOI: 10.14670/HH-16.713. View